DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
Clinical trial NCT03154749 · COMPLETED
Trial details
- NCT number
- NCT03154749
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-12-31
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.